Cargando…

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy

Studies of myocardial metabolism have reported that contractile performance at a given myocardial oxygen consumption (MVO2) can be lower when the heart is oxidizing fatty acids rather than glucose or lactate. The objective of this study is to assess the prognostic value of myocardial metabolic pheno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obrzut, Sebastian, Tiongson, Jay, Jamshidi, Neema, Phan, Huy Minh, Hoh, Carl, Birgersdotter-Green, Ulrika
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993897/ https://www.ncbi.nlm.nih.gov/pubmed/20842468 http://dx.doi.org/10.1007/s12265-010-9223-5

Ejemplares similares

Imaging and Modeling of Myocardial Metabolism
por: Obrzut, Sebastian, et al.
Publicado: (2010)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator
por: Bang, Ji Hyun, et al.
Publicado: (2015)

Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy
por: Gold, Michael R., et al.
Publicado: (2018)

Dilemma with the route of venous access for hemodialysis catheter insertion in a patient with dilated ischemic cardiomyopathy treated by cardiac resynchronization therapy
por: Ashokananda, Devanahalli, et al.
Publicado: (2016)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
por: Beiert, Thomas, et al.
Publicado: (2018)

Echocardiographic Parameters as Predictors for the Efficiency of Resynchronization Therapy in Patients with Dilated Cardiomyopathy and HFrEF
por: Pescariu, Silvius-Alexandru, et al.
Publicado: (2021)

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy
por: Gold, Michael R., et al.
Publicado: (2011)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Amiodarone and Catheter Ablation as Cardiac Resynchronization Therapy for Children with Dilated Cardiomyopathy and Wolff-Parkinson-White Syndrome
por: Kim, Sung Hoon, et al.
Publicado: (2013)

Epicardial Lead Placement for Cardiac Resynchronization Therapy in Dilated Cardiomyopathy Patient: Fine Tuning Anaesthetic Challenges
por: Damodaran, Srinath, et al.
Publicado: (2020)

More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
por: Hamdani, Nazha, et al.
Publicado: (2010)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Obesity modifies the energetic phenotype of dilated cardiomyopathy
por: Rayner, Jennifer J, et al.
Publicado: (2021)

Reversal of Wolff-Parkinson-White Syndrome induced dilated cardiomyopathy via resynchronization and subsequent accessory pathway ablation
por: Liu, Long-Bin, et al.
Publicado: (2017)

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy
por: Wang, Qi, et al.
Publicado: (2017)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Left ventricle restoration in end stage ischemic dilated cardiomyopathy
por: Jonjev, Z
Publicado: (2013)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
por: Lu, Danbo, et al.
Publicado: (2019)

Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy
por: Ziebolz, Dirk, et al.
Publicado: (2021)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
por: Canu, Marjorie, et al.
Publicado: (2021)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
por: Zhou, Mei, et al.
Publicado: (2023)

Non-ischemic Cardiomyopathy Patients Derive Superior Mortality Benefit from Cardiac Resynchronization Therapy
por: Rosman, Jonathan, et al.
Publicado: (2007)

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy
por: Yu, Ziqing, et al.
Publicado: (2017)

Prediction of Cardiac Resynchronization Therapy Response in Dilated Cardiomyopathy Using Vortex Flow Mapping on Cine Magnetic Resonance Imaging
por: Nakao, Risako, et al.
Publicado: (2019)

The subcutaneous implantable cardioverter-defibrillator should be reserved for niche indications
por: Yang, Yang, et al.
Publicado: (2022)

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
por: Tayal, Upasana, et al.
Publicado: (2022)

Anesthetic Management of Patients with Dilated Cardiomyopathy Undergoing Noncardiac Surgery
por: Li, Mengxin, et al.
Publicado: (2023)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Left Atrial Volume Determinants in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Mancuso, Frederico José Neves, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7ejrv2n2jrb9vnghdomajffdhe